Yifan Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yifan Luo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Baosen Zhou
Department of Clinical Epidemiology and Center of Evidence Based Medicine, The First Hospital of China Medical University, Shenyang, China
2 shared publications - Mingyan Jiang
Department of Pharmacy, The First Affiliated Hospital of China Medical University, Shenyang, China
2 shared publications - Yang Chu
Department of Pharmacy, the First Hospital of China Medical University, Shenyang, Liaoning, PR China
2 shared publications - Mingyan Jiang
Department of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China
1 shared publication - Shu Yang
Department of Pharmacy, The First Hospital of China Medical University, Shenyang 110001, China
1 shared publication - Shuangmin Ji
School of Pharmaceutical Sciences, Peking University, Beijing 100000, People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 21 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10459
LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance
Augmented Renal Clearance (ARC) refers to the increased renal clearance of circulating solute in critically ill patients. In this study, the analytical research method of transcriptomics combined with metabolomics was used to study the pathogenesis of ARC at the transcriptional and metabolic levels. In transcriptomics, 534 samples from 5 datasets in the Gene Expression Omnibus database were analyzed and 834 differential genes associated with ARC were obtained. In metabolomics, we used Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry to determine the non-targeted metabolites of 102 samples after matching propensity scores, and obtained 45 differential metabolites associated with ARC. The results of the combined analysis showed that purine metabolism, arginine biosynthesis, and arachidonic acid metabolism were changed in patients with ARC. We speculate that the occurrence of ARC may be related to the alteration of renal blood perfusion by LTB4R, ARG1, ALOX5, arginine and prostaglandins E2 through inflammatory response, as well as the effects of CA4, PFKFB2, PFKFB3, PRKACB, NMDAR, glutamate and cAMP on renal capillary wall permeability.
- 21 June 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (13) , 10459
Open AccessLC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance
Augmented Renal Clearance (ARC) refers to the increased renal clearance of circulating solute in critically ill patients. In this study, the analytical research method of transcriptomics combined with metabolomics was used to study the pathogenesis of ARC at the transcriptional and metabolic levels. In transcriptomics, 534 samples from 5 datasets in the Gene Expression Omnibus database were analyzed and 834 differential genes associated with ARC were obtained. In metabolomics, we used Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry to determine the non-targeted metabolites of 102 samples after matching propensity scores, and obtained 45 differential metabolites associated with ARC. The results of the combined analysis showed that purine metabolism, arginine biosynthesis, and arachidonic acid metabolism were changed in patients with ARC. We speculate that the occurrence of ARC may be related to the alteration of renal blood perfusion by LTB4R, ARG1, ALOX5, arginine and prostaglandins E2 through inflammatory response, as well as the effects of CA4, PFKFB2, PFKFB3, PRKACB, NMDAR, glutamate and cAMP on renal capillary wall permeability.
- Open Access
- 1 April 2020
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 13 (4) , 591-597
Intermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis
- 1 April 2020
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 13 (4) , 591-597
Open AccessIntermittent vs. continuous vancomycin infusion for gram-positive infections: A systematic review and meta-analysis
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 13 (1) , 68-74
Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
- 1 January 2020
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 13 (1) , 68-74
Open AccessPopulation pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance